Semnur Pharmaceuticals, Inc. Net Change in Cash
Semnur Pharmaceuticals, Inc. (SMNR) reported Net Change in Cash of -$810.62 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-08-15
- Semnur Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$240.40K, a 1551.06% decline year-over-year.
- Semnur Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $16.57K.
- Semnur Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $819.75K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$810.62K 10-Q · filed 2023-08-15 | |||
| 2023-03-31 | -$240.40K 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $819.75K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $985.58K 10-Q · filed 2022-11-16 | |||
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-15 | |||
| 2022-03-31 | $16.57K 10-Q · filed 2023-05-15 |